- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.81 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 83Z: (5~{S},6~{E},8~{S},9~{S},12~{R},15~{E})-21-chloranyl-12,20-dimethoxy-6,8,16-trimethyl-5,9-bis(oxidanyl)-2-azabicyclo[16.3.1]docosa-1(21),6,15,18(22),19-pentaene-3,11-dione(Non-covalent)
- 2 x FE: FE (III) ION(Non-covalent)
FE.2: 5 residues within 4Å:- Chain A: H.153, H.157, D.176, D.353
- Ligands: AMP.3
5 PLIP interactions:4 interactions with chain A, 1 Ligand-Ligand interactions- Metal complexes: A:H.153, A:H.157, A:D.176, A:D.353, AMP.3
FE.18: 5 residues within 4Å:- Chain B: H.153, H.157, D.176, D.353
- Ligands: AMP.19
5 PLIP interactions:4 interactions with chain B, 1 Ligand-Ligand interactions- Metal complexes: B:H.153, B:H.157, B:D.176, B:D.353, AMP.19
- 2 x AMP: ADENOSINE MONOPHOSPHATE(Non-covalent)
AMP.3: 18 residues within 4Å:- Chain A: H.47, H.157, D.176, G.177, G.207, G.208, Y.210, L.211, E.224, G.324, G.325, V.326, H.328, N.329, H.352, D.353
- Ligands: 83Z.1, FE.2
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:L.211, A:E.224, A:E.224, A:G.325, A:H.328, A:N.329, A:D.353, A:D.353
- Salt bridges: A:H.47, A:H.157
AMP.19: 18 residues within 4Å:- Chain B: H.47, H.157, D.176, G.177, G.207, G.208, Y.210, L.211, E.224, G.324, G.325, V.326, H.328, N.329, H.352, D.353
- Ligands: 83Z.17, FE.18
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:E.224, B:G.325, B:H.328, B:N.329, B:D.353, B:D.353
- Salt bridges: B:H.47, B:H.157
- pi-Stacking: B:Y.210
- 1 x GOL: GLYCEROL(Non-functional Binders)
- 7 x SO4: SULFATE ION(Non-functional Binders)
SO4.5: 8 residues within 4Å:- Chain A: Y.225, R.438, R.465, R.469, R.521, T.552, S.553
- Ligands: CP.10
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:R.469, A:T.552, A:S.553
- Salt bridges: A:R.438, A:K.463, A:R.465, A:R.521
SO4.6: 4 residues within 4Å:- Chain A: Y.430, G.431, H.442, R.532
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:H.442, A:R.532
SO4.7: 5 residues within 4Å:- Chain A: A.32, T.35, R.125, Q.133, R.134
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:T.35, A:Q.133
- Salt bridges: A:R.125, A:R.134
SO4.8: 4 residues within 4Å:- Chain A: S.169, H.317, S.318, R.319
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:S.169, A:S.318, A:S.318, A:R.319
- Salt bridges: A:H.317, A:R.319
SO4.9: 4 residues within 4Å:- Chain A: R.612, G.621, A.622, K.623
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:K.623
- Salt bridges: A:R.612, A:K.623
SO4.20: 5 residues within 4Å:- Chain B: R.438, R.469, R.521, T.552, S.553
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:R.469, B:S.553, B:S.553
- Salt bridges: B:R.438, B:K.463, B:R.521
SO4.21: 4 residues within 4Å:- Chain B: A.32, R.125, Q.133, R.134
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:T.35, B:T.35, B:Q.133
- Salt bridges: B:R.125, B:R.134
- 1 x CP: PHOSPHORIC ACID MONO(FORMAMIDE)ESTER(Non-covalent)
- 6 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.11: 6 residues within 4Å:- Chain A: Q.40, L.41, G.42, F.45, L.115
- Ligands: 83Z.1
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:Q.40, A:G.42
EDO.12: 5 residues within 4Å:- Chain A: K.245, L.246, H.258, G.259, N.260
No protein-ligand interaction detected (PLIP)EDO.13: 10 residues within 4Å:- Chain A: H.328, P.349, A.381, E.434, F.435, G.436, P.437, R.438, L.440, F.495
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.438
EDO.14: 7 residues within 4Å:- Chain A: R.67, L.68, R.70, Q.563, S.564, D.567
- Ligands: PEG.16
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.70, A:D.567
EDO.15: 4 residues within 4Å:- Chain A: G.389, R.390, E.391, Q.392
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:R.390, A:E.391, A:Q.392, A:Q.392
EDO.22: 4 residues within 4Å:- Chain B: E.66, P.437, P.560, I.561
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.66, B:I.561
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wei, J. et al., Endowing homodimeric carbamoyltransferase GdmN with iterative functions through structural characterization and mechanistic studies. Nat Commun (2022)
- Release Date
- 2022-11-16
- Peptides
- GdmN: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.81 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 83Z: (5~{S},6~{E},8~{S},9~{S},12~{R},15~{E})-21-chloranyl-12,20-dimethoxy-6,8,16-trimethyl-5,9-bis(oxidanyl)-2-azabicyclo[16.3.1]docosa-1(21),6,15,18(22),19-pentaene-3,11-dione(Non-covalent)
- 2 x FE: FE (III) ION(Non-covalent)
- 2 x AMP: ADENOSINE MONOPHOSPHATE(Non-covalent)
- 1 x GOL: GLYCEROL(Non-functional Binders)
- 7 x SO4: SULFATE ION(Non-functional Binders)
- 1 x CP: PHOSPHORIC ACID MONO(FORMAMIDE)ESTER(Non-covalent)
- 6 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wei, J. et al., Endowing homodimeric carbamoyltransferase GdmN with iterative functions through structural characterization and mechanistic studies. Nat Commun (2022)
- Release Date
- 2022-11-16
- Peptides
- GdmN: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B